medigraphic.com

2010, Number 6

<< Back Next >>

Rev Med MD 2010; 1.2 (6)

Síndrome de Ovario Poliquístico

López-Iñiguez Á

Language: Spanish
References: 14
Page: 11-18
PDF size: 148.54 Kb.


ABSTRACT

No abstract


REFERENCES

  1. Vilda Discacciati. Ovarian Polycystic Syndrome. Evid Actual Pract Ambul 2007; 10(6):178-180.

  2. Ehrmann D. A. Polycyistic Ovary Syndrome. N Engl J Med 2005; 352:1223-36.

  3. Revised 2003 Consensous on Diagnostic Criteria and long term health risks related to Polycystic Ovary Syndrome. Hum Reprod 2004; 19:41-7.

  4. Guerra Gallardo, Cuixart Maria, et al. Síndrome del Ovario Poliquístico. Guías Clínicas 2006; 6 (22).

  5. Homburg R, Armar N, et al. Influence of serum Luteinizing Hormone concentrations on Ovulation, conception, and early pregnancy loss in Polycystic Ovary Syndrome. BMJ 1998; 297:1024-1026.

  6. Nestler J. E. Metformin for the Treatment of Polycystic Ovary Syndrome. N Engl J Med. 2008; 358: 47-54.

  7. Legro R. Clomiphene, Metformin or Both For Infertility in The Polycystic Ovary Syndrome. T N Engl J Med. 2007; 356: 551-66.

  8. Iturra A. Síndrome de Ovario Poliquístico: la evaluación ultrasonografica en la practica diaria. Rev Chil Ultrasonog 2008; 11:18-21.

  9. Vivas C. Síndrome de Ovario Poliquístico, Endometrio y Riesgo de Aborto. Rev Col Ginel Obst 2005; 4: 303-309.

  10. Builes A., Díaz I., et al. Caracterización Clínica y Bioquímica de la Mujer con Síndrome de Ovario Poliquístico. Rev Col Ginel Obst 2006; 57: 36-44.

  11. Ott J., Kurz C., et al. Pregnancy outcome in women with Polycystic Ovary Syndrome comparing the effects of laparoscopic ovarían drilling and clomiphene citrate stimulation in women pre-treated witn metformin: a restrospective study. Rep Bio Endocrinol 2010, 8:45 doi: 10.1186/1477-7827 – 8- 45.

  12. Sathyapalan T., Atkin S. Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity. Hindawi Publishing Corporation. 2010 doi: 1155/2010/758656.

  13. Alexander C., Tangchitnob E., et al. Polycystic Ovary Syndrome: A Major Unrecognized Cardiovascular Risk Factor in Women. Review Obstet Ginecol 2009; 2(4): 232-239 doi: 10.3909 / riog0094.

  14. Ciccone M., Favale S., et al. Anteroposterior diameter of the infrarenal abdominal aorta is higher in women with polycystic ovary syndrome. Vascular Health and Risk Management 2009; 5 561-566.




2020     |     www.medigraphic.com